HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yvette Michotte Selected Research

des-Asp(1)-des-Arg(2)-Ile(5)- angiotensin II

3/2010Involvement of the AT1 receptor subtype in the effects of angiotensin IV and LVV-haemorphin 7 on hippocampal neurotransmitter levels and spatial working memory.
7/2009Angiotensin IV and LVV-haemorphin 7 enhance spatial working memory in rats: effects on hippocampal glucose levels and blood flow.
8/2006Involvement of the somatostatin-2 receptor in the anti-convulsant effect of angiotensin IV against pilocarpine-induced limbic seizures in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yvette Michotte Research Topics

Disease

23Seizures (Absence Seizure)
03/2013 - 08/2002
9Parkinson Disease (Parkinson's Disease)
03/2015 - 11/2004
9Hypothermia
11/2013 - 10/2003
9Stroke (Strokes)
11/2013 - 05/2005
9Epilepsy (Aura)
07/2012 - 08/2002
8Brain Ischemia (Cerebral Ischemia)
11/2013 - 09/2008
7Infarction (Infarctions)
11/2013 - 04/2009
4Ischemic Stroke
11/2013 - 04/2009
3Gliosis
08/2012 - 07/2010
3Memory Disorders (Memory Loss)
04/2011 - 07/2009
2Nervous System Diseases (Neurological Disorders)
01/2015 - 03/2013
2Ischemia
03/2013 - 09/2008
2Catalepsy
06/2012 - 11/2010
2Drug Resistant Epilepsy
05/2011 - 01/2007
2Status Epilepticus (Complex Partial Status Epilepticus)
01/2011 - 06/2010
2Alzheimer Disease (Alzheimer's Disease)
01/2011 - 09/2008
2Cognitive Dysfunction
03/2010 - 01/2008
1Mood Disorders (Mood Disorder)
06/2015
1Disease Progression
01/2015
1Mitochondrial Diseases (Mitochondrial Disease)
01/2015
1Dyskinesias (Dyskinesia)
10/2014
1Temporal Lobe Epilepsy
05/2011
1Atrophy
04/2011
1Neuroinflammatory Diseases
11/2010
1Amnesia (Dissociative Amnesia)
07/2009

Drug/Important Bio-Agent (IBA)

17Pilocarpine (Ocusert)FDA LinkGeneric
03/2013 - 08/2002
14Glutamic Acid (Glutamate)FDA Link
06/2015 - 08/2002
12Anticonvulsants (Antiepileptic Drugs)IBA
12/2011 - 03/2004
9Dopamine (Intropin)FDA LinkGeneric
11/2010 - 10/2003
8Neuroprotective AgentsIBA
11/2013 - 10/2003
8Endothelin-1 (Endothelin 1)IBA
11/2013 - 10/2003
6Serotonin (5 Hydroxytryptamine)IBA
01/2008 - 05/2004
5LigandsIBA
11/2010 - 03/2004
4Proteins (Proteins, Gene)FDA Link
01/2015 - 02/2005
4gamma-Aminobutyric Acid (GABA)IBA
12/2010 - 08/2002
3Caspase 3 (Caspase-3)IBA
03/2013 - 12/2005
3Pentylenetetrazole (Metrazol)IBA
03/2013 - 07/2009
3Neurotransmitter Agents (Neurotransmitter)IBA
05/2011 - 01/2008
3des-Asp(1)-des-Arg(2)-Ile(5)- angiotensin IIIBA
03/2010 - 08/2006
3Amino AcidsFDA Link
09/2005 - 03/2004
2Peptides (Polypeptides)IBA
01/2015 - 01/2008
2GhrelinIBA
07/2012 - 04/2012
2NeuropeptidesIBA
07/2012 - 04/2012
2HU 211 (HU 210)IBA
06/2012 - 11/2010
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
12/2011 - 08/2006
2Bupropion (Wellbutrin)FDA LinkGeneric
11/2011 - 01/2008
2CitalopramFDA LinkGeneric
11/2011 - 12/2004
2Biomarkers (Surrogate Marker)IBA
05/2011 - 06/2002
2Cystine (L-Cystine)IBA
04/2011 - 10/2008
2Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
01/2008 - 03/2004
23,4-dihydroxyphenylglycolIBA
01/2008 - 03/2004
25-HT1A Serotonin ReceptorIBA
12/2005 - 05/2004
2Oxidopamine (6 Hydroxydopamine)IBA
05/2005 - 11/2004
1alpha-SynucleinIBA
03/2015
1SynucleinsIBA
01/2015
1UbiquitinIBA
01/2015
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2015
1lactacystinIBA
01/2015
1Levodopa (L Dopa)FDA LinkGeneric
10/2014
1theanineIBA
03/2013
1TeaIBA
03/2013
1SolutionsIBA
03/2013
1Glial Fibrillary Acidic ProteinIBA
08/2012
1Cannabinoid Receptor AgonistsIBA
06/2012
1cresyl violetIBA
05/2012
1LipopolysaccharidesIBA
05/2012
1OximesIBA
12/2011
1L 779976IBA
12/2011
1L803087IBA
12/2011
1L796778IBA
12/2011
1Antidepressive Agents (Antidepressants)IBA
11/2011
1Reboxetine (Vestra)IBA
11/2011
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2011
1CytokinesIBA
05/2011
1Norepinephrine (Noradrenaline)FDA LinkGeneric
05/2011
1Acetylcysteine (Siran)FDA LinkGeneric
04/2011
1Glutathione (Reduced Glutathione)IBA
04/2011
1Vesicular Glutamate Transport ProteinsIBA
01/2011
1benzyloxyaspartate (TBOA)IBA
01/2011
1Amino Acid Transport System X-AG (Glutamate Transporter)IBA
11/2010
1CannabinoidsIBA
11/2010
1ElementsIBA
11/2010
1Nerve Growth Factors (Neurotrophins)IBA
07/2010
1GlycogenIBA
07/2010
1Kainic Acid (Kainate)IBA
06/2010
1KetamineFDA LinkGeneric
06/2010
1Diazepam (Valium)FDA LinkGeneric
06/2010
11,2,3,4,4a,5,10,10a- octahydro- 6- methoxy- 1- methylbenz(g)quinoline- 3- carboxylic acid 4-(4-nitrophenyl)piperazine amideIBA
03/2010
1AutoreceptorsIBA
03/2010
1valylvaline (Val-Val)IBA
03/2010
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
10/2009
1Insulin-Like Growth Factor Binding ProteinsIBA
04/2009
1Insulin-Like Growth Factor I (IGF-1)IBA
04/2009
1AntiportersIBA
10/2008
1AntibodiesIBA
10/2008

Therapy/Procedure

8Therapeutics
11/2013 - 08/2002
3Induced Hypothermia
11/2013 - 02/2005
1Lasers (Laser)
08/2012
1Vagus Nerve Stimulation
05/2011
1Analgesia
11/2010